🔔 Earnings Alert
Rossari Biotech's Q2 FY24-25 results show net sales of Rs 335.99 crore, up 1.2% Y-o-Y, but stock drops 4.28% due to unmet market expectations.
based on 4 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 4 analysts offering long term price targets for Rossari Biotech Ltd. An average target of ₹951.25
Source: S&P Global Market Intelligence
Rossari Biotech Ltd price forecast by 4 analysts
Upside of8.61%
High
₹1034
Target
₹951.25
Low
₹885
Rossari Biotech Ltd target price ₹951.25, a slight upside of 8.61% compared to current price of ₹830.3. According to 4 analysts rating.
Excluding Excise Duty and Other Income, represents Net Revenue
Rossari Biotech Ltd revenue growth forecast
Expected growth rate Q1, FY2026:36.15%
Forecast
Actual
Including amortisation and stock based compensations
Rossari Biotech Ltd EPS growth forecast
EPS estimate Q1, FY2026:51.73%
Forecast
Actual
Source: S&P Global Market Intelligence
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | -6.46 % |
3 Month Return | + 6.86 % |
1 Year Return | + 10.03 % |
Market Stats | |
Previous Close | ₹875.80 |
Open | ₹870.00 |
Volume | 1.34L |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹4,842.23Cr |
P/E Ratio | 34.86 |
PEG Ratio | 8.85 |
Market Cap | ₹4,842.23 Cr |
P/B Ratio | 3.88 |
EPS | 23.66 |
Dividend Yield | 0 |
Sector | Chemicals |
ROE | 10.96 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
BUY | ₹4,842.23 Cr | 3.62% | 0.53 | ₹130 Cr | ₹1,830 Cr | |
NA | ₹9,427.71 Cr | 44.63% | 0.56 | ₹484 Cr | ₹7,929 Cr | |
BUY | ₹18,216.35 Cr | 134.19% | 0.74 | ₹491 Cr | ₹6,419 Cr | |
HOLD | ₹6,887.73 Cr | 75.97% | 0.75 | ₹95 Cr | ₹1,752 Cr | |
₹6,932.82 Cr | 22.63% | 0.54 | ₹164 Cr | ₹2,603 Cr |
Organisation | Rossari Biotech Ltd |
Headquarters | Mumbai |
Industry | Chemicals |
E-voting on shares | Click here to vote |
Key events for Rossari Biotech Ltd
Following the release of Q2 FY24-25 earnings, Rossari Biotech's stock fell 4.28% due to disappointing results and concerns over growth and profitability pressures.
Rossari Biotech Reports Q2 Profit Growth - 20 Oct, 2024
Rossari Biotech reported a 7.3% YoY increase in net profit to ₹35.3 crore for Q2 FY2024, with revenue rising 1.8% to ₹498.3 crore.
Rossari Biotech Reports Q2 Earnings Growth - 19 Oct, 2024
Rossari Biotech Ltd announced a 7% increase in net profit to ₹35 crore and a 2% rise in revenue to ₹498 crore for Q2 FY2024. The company also appointed Gurudas Aras as a Non-Executive Independent Director and reappointed Aseem Dhru for a second term. Shares closed down 0.48% on October 18.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Profit Spike
Netprofit is up for the last 3 quarters, 34.13 Cr → 35.33 Cr (in ₹), with an average increase of 1.7% per quarter
Revenue Rich
Revenue is up for the last 4 quarters, 467.29 Cr → 499.36 Cr (in ₹), with an average increase of 2.2% per quarter
Retail Holding Up
Retail Investor have increased holdings from 9.90% to 10.98% in Jun 2024 quarter
Against Peers
In the last 3 years, PCBL Ltd has given 316.1% return, outperforming this stock by 354.8%
Against Peers
In the last 1 year, PCBL Ltd has given 158.4% return, outperforming this stock by 148.4%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 68.32% of holdings in Jun 2024 quarter
MF Holding Down
Mutual Funds have decreased holdings from 13.27% to 12.96% in Jun 2024 quarter
FII Holding Down
Foreign Institutions have decreased holdings from 4.03% to 3.83% in Jun 2024 quarter
Price Dip
In the last 3 years, ROSSARI stock has moved down by -38.7%
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 68.32% | 0.00 | |
Foreign Institutions | 3.83% | ||
Mutual Funds | 12.96% | ||
Retail Investors | 10.98% | 10.89 | |
Others | 3.91% |
Rossari Biotech Ltd in the last 5 years
Lowest (28.32x)
June 4, 2024
Today (34.86x)
October 18, 2024
Industry (62.81x)
October 18, 2024
Highest (90.67x)
September 15, 2021
Rossari Biotech Ltd’s net profit jumped 7.22% since last year same period to ₹35.33Cr in the Q2 2024-2025. On a quarterly growth basis, Rossari Biotech Ltd has generated 1.23% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2024, Rossari Biotech Ltd has declared dividend of ₹0.50 - translating a dividend yield of 0.12%.
Read More about DividendsBearish
Neutral
Bullish
Rossari Biotech Ltd is currently in a Bearish trading position according to technical analysis indicators.
Rossari Biotech Ltd (ROSSARI) share price today is ₹830.3
Rossari Biotech Ltd is listed on NSE
Rossari Biotech Ltd is listed on BSE
PE Ratio of Rossari Biotech Ltd is 34.86
PE ratio = Rossari Biotech Ltd Market price per share / Rossari Biotech Ltd Earnings per share
Today’s traded volume of Rossari Biotech Ltd(ROSSARI) is 1.34L.
Today’s market capitalisation of Rossari Biotech Ltd(ROSSARI) is ₹4842.23Cr.
Rossari Biotech Ltd(ROSSARI | Price |
---|---|
52 Week High | ₹972.7 |
52 Week Low | ₹656.95 |
Rossari Biotech Ltd(ROSSARI) share price is ₹830.3. It is down -14.64% from its 52 Week High price of ₹972.7
Rossari Biotech Ltd(ROSSARI) share price is ₹830.3. It is up 26.39% from its 52 Week Low price of ₹656.95
Rossari Biotech Ltd(ROSSARI | Returns |
---|---|
1 Day Returns | -45.5% |
1 Month Returns | -6.46% |
3 Month Returns | 6.86% |
1 Year Returns | 10.03% |